Molecular characterization of H1N1 influenza A viruses from human cases in North America

Chinese Science Bulletin

Volumn 54, Issue 13, 2009, Pages 2179-2192

  Wu, Bin ^a,c   Wang, ChengMin ^a,b   Dong, GuoYing ^a   Luo, Jing ^a,b   Zhao, BaoHua ^c   He, HongXuan ^a  

^a INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c HEBEI NORMAL UNIVERSITY   (China)

Author keywords

H1N1 subtype; Influenza A viruses; Molecular characterization; North America

Indexed keywords

ANIMALIA; INFLUENZA A VIRUS; INFLUENZAVIRUS A; MAMMALIA; ORTHOMYXOVIRIDAE; SUIDAE;

EID: 70349316673     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1007/s11434-009-0421-y     Document Type: Article

References (41)

1. Webster R G, Bean W J, Gorman O T, et al. Evolution and ecology of influenza A viruses. Microbiol Rev, 1992, 56: 152-179
2. Peiris J S, de J, Guan Y. Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev, 2007, 20: 243-267
3. Kumar S, Tamura K, Jakobsen I B, et al. MEGA2: Molecular evolutionary genetics analysis software. Bioinformatics, 2001, 17: 1244-1245
4. Thompson J D, Higgins D G, Gibson T J. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res, 1994, 22: 4673-4680
5. Schwede T, Kopp J, Guex N, et al. SWISS MODEL: An automated protein homology-modeling server. Nucleic Acids Res, 2003, 31: 3381-3385
6. William H, Andrew D, Klaus S. VMD: Visual molecular dynamics. J Mol Grap, 1996, 14: 33-38
7. Gabriel G, Herwig A, Klenk H D. Interaction of polymerase subunit PB2 and NP with importin alpha1 is a determinant of host range of influenza A virus. PLoS Pathog, 2008, 4: e11
8. Qi X, Li X, Rider P, et al. Molecular characterization of highly pathogenic H5N1 avian influenza A viruses isolated from raccoon dogs in China. PLoS ONE, 2009, 4(3): e4682, doi:10.1371/journal.pone.0004682
9. Obenauer J C, Denson J, Mehta P K, et al. Large-scale sequence analysis of avian influenza isolates. Science, 2006, 311: 1576-1580
10. Jackson D, Hossain M J, Hickman D, et al. A new influenza virus virulence determinant: The NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci USA, 2008, 105: 4381-4386
11. Atsushi O, Takashi M, Hideo T. Protonation of histidine and histidine-tryptophan interaction in the activation of the M2 ion channel from influenza A virus. Biochemistry, 2001, 40: 6053-6060
12. Suzuki H, Saito R, Masuda H, et al. Emergence of amantadine-resistant influenza A viruses: Epidemiological study. J Infect Chemother, 2003, 9: 195-200
13. Scholtissek C, Quack G, Klenk H D, et al. How to overcome resistance of influenza A viruses against adamantane derivatives. Antiviral Res, 1998, 37: 83-95
14. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a Norel Swine-Origin Influenza A (H1N1) Virus in Hamans. N Engl J Med, 2009, doi: 10.1056/NEJMoa0903810
15. Parrish C R, Kawaoka Y. The origins of new pandemic viruses: The acquisition of new host ranges by canine parvovirus and influenza A viruses. Annu Rev Microbiol, 2005, 59: 553-586
16. Skehel J J, Wiley D C. Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin. Annu Rev Biochem, 2000, 69: 531-569
17. Weis W, Brown J H, Cusack S, et al. Structure of the influenza virus hemagglutinin complexed with its receptor, sialic acid. Nature, 1988, 333: 426-431
18. Rogers G N, Paulson J C, Daniels R S, et al. Single amino acid substitutions in influenza hemagglutinin change receptor binding specificity. Nature, 1983, 304: 76-78
19. Monto A S. The role of antivirals in the control of influenza. Vaccine, 2003, 21: 1796-1800
20. Hay A J, Wolstenholm A J, Skehel J J, et al. The molecular basis of the specific anti-influenza action of amantadine. EMBO J, 1985, 4: 3021-3024
21. Pinto L H, Holsinger L J, Lamb L A. Influenza virus M2 protein has ion channel activity. Cell, 1992, 69: 517-528
22. Madren L K, Shipman C, Hayden F G. In vitro inhibitory effects of combinations of anti-influenza agents. Antivir Chem Chemother, 1995, 6: 109-113
23. Varghese J H, McKimm-Breschkin J L, Caldwell J B, et al. The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor. Proteins, 1992, 14: 327-332
24. Von Itzstein M, Wu W Y, Kok G K, et al. Rational design of potent sialidase based inhibitors of influenza virus protection. Nature, 1993, 363: 418-423
25. Hayden FG. Amantadine and rimantadine-clinical aspects. In: Richman D D, ed. Antiviral Drug Resistance. New York: Wiley, 1996. 59-77
26. Ziegler T, Hemphill M L, Ziegler M L, et al. Low incidence of rimantadine resistance in field isolates of influenza A viruses. J Infect Dis, 1999, 180: 935-939
27. Bright R A, Medina M, Xu X, et al. Incidence of adamantine resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet, 2005, 366: 1175-1181
28. Ilyushina N A, Govorkova E A, Webster R G. Detection of amantadine-resistant variants among avian influenza viruses isolated in North America and Asia. Virology, 2005, 341: 102-106
29. Monto A S, Fleming D M, Henry D, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections. J Infect Dis, 1999, 180: 254-261
30. Lew W, Chen X, Kim C U. Discovery and development of GS4104 (oseltamivir): An orally active influenza neuraminidase inhibitor. Curr Med Chem, 2000, 7: 663-672
31. McKimm-Breschkin J L. Resistance of influenza viruses to neraminidase inhibitors-a review. Antivir Res, 2000, 47: 1-17
32. McKimm-Breschkin J L. Management of influenza virus infections with neuraminidase inhibitors: detection, incidence, and implications of drug resistance. Treat Respir Med, 2005, 4: 107-116
33. Kiso M, Mitamura K, Sakai-Tagawa Y, et al. Resistant influenza A viruses in children treated with oseltamivir: Descriptive study. Lancet, 2004, 364: 759-765
34. Gubareva L V, Matrosovich M N, Brenner M K, et al. Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. J Infect Dis, 1998, 178: 1257-1262
35. Robert M K, Wei M Y, Diana L N, et al. Intracellular warfare between human influenza viruses and human cells: The roles of the viral NS1 protein. Virology, 2003, 309: 181-189
36. Stacey S C, Naomi D S, Gabriele N, et al. Influenza virus NS1 protein induces apoptosis in cultured cells. J Virol, 2001, 75: 7875
37. Adolfo G S, Andrej E, Demetrius M, et al. influenza a virus lacking the ns1 gene replicates in interferon-deficient systems. Virology, 1998, 252: 324-330
38. Sang H S, Erich H, Robert G W. The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses. Virus Res, 2004, 103: 107-113
39. Gary K G, Mirella S, Terrence M T, et al. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: The role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc Natl Acad Sci USA, 2002, 99: 10736-10741
40. Aleksandr S L, Samita A, Richard J W, et al. Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: The role of cytokines and B- and T-cell responses. J Gen Virol, 2005, 86: 1121-1130
41. Morgan S, Carlo S. PDZ domains and the organization of supramolecular complexes. Annu Rev Neurosci, 2001, 24: 1-29